US Edition
US health authorities to set targets for lowering drug prices
- On May 12, 2025, the U.S. Administration issued an executive order targeting lower drug prices by setting federal price targets and encouraging voluntary manufacturer compliance.
- This effort follows longstanding concerns that the U.S. Pays higher drug prices than other countries due to lack of government price negotiation and complex supply chain intermediaries.
- The policy proposes a 'most favored nation' approach linking U.S. Drug prices to lower foreign prices while planning investigations to pressure European nations to pay more for medications.
- Officials noted U.S. Drug prices often exceed foreign prices by three to five times, citing examples where identical medications cost $1,000 in the U.S. And $88 abroad, affecting nearly one-third of patients who skip medications due to cost.
- The order lacks enforcement mechanisms and relies on voluntary compliance, suggesting that drug price reductions are uncertain and the broader challenges involving middlemen and industry lobbying remain unresolved.
17 Articles
17 Articles
Biden Policies Continue to Raise Drug Prices & Hurt Patients
by Michael Busler at CDN - When government agencies are guided more by politics than policy, the result is often higher costs, reduced access, and unintended harm to the very people they claim to protect. Under former Chair Lina Khan, the Federal Trade Commission (FTC) too often embraced this playbook, launching investigations and reports designed more to feed a narrative than … Click to read the rest HERE-> Biden Policies Continue to Raise Drug…
Spanberger: time to crack down on insurer practices that keep drug costs up
Democratic candidate for governor Abigail Spanberger wants to crack down on a range of insurer practices she says are keeping drug costs up, and hitting Virginians with abusive billing practices and scam coverage.
Coverage Details
Bias Distribution
- 46% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
